Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

被引：0
|
作者：
Yoon, Shinkyo [1 ]
Yoon, Dok Hyun [1 ]
Kim, Shin [2 ]
Lee, Kyoungmin [2 ]
Kang, Eun Hee [2 ]
Lee, Sang-wook [3 ]
Park, Chan-Jeoung [4 ]
Park, Chan-Sik [5 ]
Huh, Jooryung [5 ]
Suh, Cheolwon [2 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [12] Clinical Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Are Still Essential in the Rituximab Era
    de Padua Covas Lage, Luis Alberto
    Costa, Renata Oliveira
    Hallack Neto, Abrahao Elias
    Siqueira, Sheila
    Santucci, Rodrigo
    de Paula, Henrique Moura
    Pereira, Juliana
    BLOOD, 2014, 124 (21)
  • [13] Prognostic impact of bone marrow involvement for patients with diffuse large B-cell lymphoma in the era of rituximab
    Kang, B. W.
    Lee, Y. J.
    Chae, Y. S.
    Moon, J. H.
    Kim, J. G.
    Sohn, S. K.
    Suh, J. S.
    Park, T. I.
    Kim, M. K.
    Hyun, M. S.
    Kim, H. J.
    Lee, J.
    Yang, D. H.
    Bae, S. H.
    Ryoo, H.
    Kwon, K. Y.
    Kim, J. Y.
    Do, Y. R.
    Park, K. U.
    Kim, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [14] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
    Zhou, Zheng
    Sehn, Laurie H.
    Rademaker, Alfred W.
    Gordon, Leo I.
    LaCasce, Ann S.
    Crosby-Thompson, Allison
    Vanderplas, Ann
    Zelenetz, Andrew D.
    Abel, Gregory A.
    Rodriguez, Maria A.
    Nademanee, Auayporn
    Kaminski, Mark S.
    Czuczman, Myron S.
    Millenson, Michael
    Niland, Joyce
    Gascoyne, Randy D.
    Connors, Joseph M.
    Friedberg, Jonathan W.
    Winter, Jane N.
    BLOOD, 2014, 123 (06) : 837 - 842
  • [15] Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era
    Mounier, Nicolas
    Gisselbrecht, Christian
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 209 - 213
  • [16] Diffuse large B cell lymphoma: prognostic factors in the rituximab era
    Guevara Arismendy, Natalia Maria
    Jaramillo Arbelaez, Patricia Elena
    Gaviria Jaramillo, Lina Maria
    IATREIA, 2013, 26 (03) : 302 - 312
  • [17] Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era
    Liang, Xiping
    Hu, Renzhi
    Li, Qiying
    Wang, Chaoyu
    Liu, Yao
    EXPERIMENTAL HEMATOLOGY, 2023, 122 : 1 - 9
  • [18] Prognostic impact for different sites of extranodal involvement in patients with diffuse large B-cell lymphoma in the rituximab era
    Takahashi, H.
    Tomita, N.
    Yokoyama, M.
    Tsunoda, S.
    Yano, T.
    Murayama, K.
    Hashimoto, C.
    Tamura, K.
    Sato, K.
    Fujita, H.
    Ishigatsubo, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [19] Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era
    Hsueh-Ju Lu
    Yu-Chung Huang
    Chun-Yu Liu
    Man-Hsin Hung
    Ming-Hung Hu
    Chia-Yun Wu
    Ying-Chung Hong
    Liang-Tsai Hsiao
    Jyh-Pyng Gau
    Jin-Hwang Liu
    Hui-Chi Hsu
    Tzeon-Jye Chiou
    Cheng-Hwai Tzeng
    Yuan-Bin Yu
    Annals of Hematology, 2013, 92 : 1495 - 1501
  • [20] PROGNOSTIC IMPACT FOR DIFFERENT SITES OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Takahashi, H.
    Tomita, N.
    Yokoyama, M.
    Tsunoda, S.
    Yano, T.
    Murayama, K.
    Hashimoto, C.
    Tamura, K.
    Sato, K.
    Ishigatsubo, Y.
    ANNALS OF ONCOLOGY, 2011, 22 : 195 - 195
12345